Intraventricular streptokinase increases cerebrospinal fluid D dimer in preterm infants with posthaemorrhagic ventricular dilatation.
Failure to lyse multiple small blood clots in the cerebrospinal fluid (CSF) reabsorption pathways may be one of the mechanisms leading to posthaemorrhagic ventricular dilatation (PHVD). It has been suggested that intraventricular administration of streptokinase may resolve PHVD but it is not known whether such treatment produces an increase in fibrin degradation products in the CSF. Ventricular CSF was collected from six infants with PHVD before and during intraventricular treatment with streptokinase 1000 units/h. In all six infants, CSF D dimer increased during streptokinase treatment. Median D dimer before treatment was 1642 micrograms/l and during treatment 5440 micrograms/l (p < 0.05). Undetectable D dimer levels in plasma during streptokinase treatment ruled out the possibility that D dimer had merely diffused into the CSF. This augmentation of local fibrinolysis may have therapeutic potential. There was no evidence of systemic fibrinolysis.
Whitelaw
A
A
Department of Paediatrics, Aker University Hospital, Oslo, Norway.
Mowinckel
M C
MC
Larsen
M L
ML
Røkås
E
E
Abildgaard
U
U
D002543:Cerebral Hemorrhage / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D002552:Cerebral Ventricles; D004108:Dilatation, Pathologic / Q000134:cerebrospinal fluid / Q000188:drug therapy; D005338:Fibrin Fibrinogen Degradation Products / Q000134:cerebrospinal fluid*; D006801:Humans; D007231:Infant, Newborn; D007276:Injections, Intraventricular; D013300:Streptokinase / Q000008:administration & dosage*; D015912:Thrombolytic Therapy
D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D013300:Streptokinase